Nurulamin M. Noor

Cambridge, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 102 publications

Effect of JAK inhibitors on extraintestinal manifestations and concurrent immune-mediated inflammatory diseases in patients with inflammatory bowel disease.

Effect of JAK inhibitors on extraintestinal manifestations and concurrent immune-mediated inflammatory diseases in patients with inflammatory bowel disease.

Journal: Journal of Crohn's & colitis

Published: September 05, 2026

ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease.

ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease.

Journal: Journal of Crohn's & colitis

Published: July 08, 2026

ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment.

ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment.

Journal: Journal of Crohn's & colitis

Published: July 07, 2026

ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment.

ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment.

Journal: Journal of Crohn's & colitis

Published: July 01, 2026

Optimizing trial design for evaluating combination therapies in IBD.

Optimizing trial design for evaluating combination therapies in IBD.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: June 10, 2026

Magnetic resonance imaging-based simplified MaRIA scores are associated with future surgery in Crohn's disease, but modest correlation with ileo-colonoscopic inflammation limits their utility in clinical trials: results from the PROFILE trial.

Magnetic resonance imaging-based simplified MaRIA scores are associated with future surgery in Crohn's disease, but modest correlation with ileo-colonoscopic inflammation limits their utility in clinical trials: results from the PROFILE trial.

Journal: Journal of Crohn's & colitis

Published: May 22, 2026

Bayesian prior elicitation on the efficacy of medical therapies in perianal fistulizing Crohn's disease.

Bayesian prior elicitation on the efficacy of medical therapies in perianal fistulizing Crohn's disease.

Journal: Journal of Crohn's & colitis

Published: May 10, 2026

Entering a new age of innovation in IBD clinical trial design.

Entering a new age of innovation in IBD clinical trial design.

Journal: Med (New York, N.Y.)

Published: May 08, 2026

Retention in trials: a qualitative evidence synthesis of studies reporting participant reasons for trial non-completion.

Retention in trials: a qualitative evidence synthesis of studies reporting participant reasons for trial non-completion.

Journal: BMJ open

Published: April 20, 2026

Two trials with two different answers: potential for Bayesian re-analysis in a Crohn's disease clinical trial.

Two trials with two different answers: potential for Bayesian re-analysis in a Crohn's disease clinical trial.

Journal: Gastroenterology

Published: April 04, 2026

Redefining Early Intervention and the Window of Opportunity in Crohn's Disease.

Redefining Early Intervention and the Window of Opportunity in Crohn's Disease.

Journal: Gastroenterology & hepatology

Published: March 26, 2026

Entering a new GALAXI: The importance of long-term data in Crohn's disease clinical trials.

Entering a new GALAXI: The importance of long-term data in Crohn's disease clinical trials.

Journal: Inflammatory bowel diseases

Published: March 24, 2026

Showing 1-12 of 102

Last Updated: 09/26/2026